We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Seville, Spain

ICHNO 2026

Session

Immuno-oncology
Poster
Peripheral Blood Immune Cell Profiling by Single cell RNA sequencing (scRNA-seq) to Predict Anti-PD1 Efficacy in Recurrent and/or Metastatic SCCHN
Séverine Carlier, Belgium
-99
Safety and Efficacy of Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Recent Clinical Studies
Yang Su, China
-124
NEUTROPHIL/LYMPHOCYTE RATIO(NLR): A POTENTIAL BIOMARKER IN PATIENTS WITH H&N SQUAMOUS CELL CARCINOMA TREATED WITH IMMUNE CHECKPOINT INHIBITORS
Marianna Caterino, Italy
-125
Prognostic impact of PD-L1 expression in tumour cells and tumour infiltrating lymphocytes in locally advanced nasopharyngeal carcinoma
Ahitagni Biswas, India
-189
Second-line treatment outcomes in immune-experienced recurrent/metastatic HNSCC: results from the REALKEY study
Armando Di Bello, Italy
-296
Cetuximab in treatment sequencing after immune-checkpoint inhibitor in recurrent/metastatic head and neck squamous cell carcinoma: a systematic review
Riccardo Gili, Italy
-362
Development of a MUC1-C–Specific Antibody–Drug Conjugate for the Treatment of Head and Neck Cancer
Surender Kharbanda, USA
-429
IMMUN-NEO-ORL: Evaluation of the Efficacy of Neoadjuvant Immunochemotherapy in Patients with Locally Advanced HNSCC Unresectable
Marine ORIEL, France
-431